Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03833674 · ClinicalTrials.gov registry record · NA
FLO2 for Recovery After SCI
A NA study of Spinal Cord Injury (SCI), sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT03833674 is a NA study of Spinal Cord Injury (SCI) that has completed, run by University of Florida. The registered enrollment target is 43 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03833674, a NA study of Spinal Cord Injury (SCI), has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
Acute intermittent hypoxia (AIH) involves short (\~1-2min) bouts of breathing low oxygen air to stimulate spinal neuroplasticity. Studies in rodents and humans indicate that AIH improves motor function after spinal cord injury (SCI). This study will use a double blind, cross-over design to test if the combination of AIH and respiratory strength training improves breathing function more than either approach alone in adults with chronic SCI.
Conditions Studied
Interventions
- OTHER Daily AIH Block
- OTHER Sham dAIH Block
- OTHER Respiratory Strength Training Block
- OTHER AIH + Strength Training Block
Study Locations (1)
Florida
- Brooks Rehabilitation Hospital - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2020-08-15 |
| Est. Completion | 2024-02-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03833674
The ClinicalTrials.gov registry entry for NCT03833674 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Cord Injury (SCI) appearing as the primary indexed condition, and to 4 interventions - of which Daily AIH Block is the first listed.
NCT03833674 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03833674 about?
NCT03833674 is a clinical study titled "FLO2 for Recovery After SCI". Acute intermittent hypoxia (AIH) involves short (\~1-2min) bouts of breathing low oxygen air to stimulate spinal neuroplasticity. Studies in rodents and humans indicate that AIH improves motor function after spinal cord injury (SCI). This study will use a double blind, cross-over design to test if t...
What is the current status of trial NCT03833674?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2020-08-15. Estimated completion is 2024-02-20.
What conditions does trial NCT03833674 study?
This clinical trial studies the following conditions: Spinal Cord Injury (SCI).
What interventions are being tested in trial NCT03833674?
The interventions under investigation include: Daily AIH Block (OTHER), Sham dAIH Block (OTHER), Respiratory Strength Training Block (OTHER), AIH + Strength Training Block (OTHER).
Who is sponsoring clinical trial NCT03833674?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03833674 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury (SCI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.